These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2171324)

  • 1. Apocrine carcinoma of the breast.
    Mazoujian G
    Am J Clin Pathol; 1990 Oct; 94(4):485-6. PubMed ID: 2171324
    [No Abstract]   [Full Text] [Related]  

  • 2. The spectrum of apocrine lesions of the breast.
    O'Malley FP; Bane AL
    Adv Anat Pathol; 2004 Jan; 11(1):1-9. PubMed ID: 14676636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Just Blow It Off Because It's Apocrine?
    Russell DH
    Int J Surg Pathol; 2020 Jun; 28(4):412-414. PubMed ID: 31496335
    [No Abstract]   [Full Text] [Related]  

  • 4. Pure apocrine carcinoma of the female breast presenting as a cyst: a case report.
    Taccagni GL; Sironi M; Dell'Antonio G; Cantaboni A
    Pathologica; 1985; 77(1047):91-9. PubMed ID: 3001624
    [No Abstract]   [Full Text] [Related]  

  • 5. Apocrine carcinoma of the breast.
    Gădăleanu V; Galatâr N
    Morphol Embryol (Bucur); 1986; 32(1):33-8. PubMed ID: 3010089
    [No Abstract]   [Full Text] [Related]  

  • 6. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
    Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
    Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
    [No Abstract]   [Full Text] [Related]  

  • 7. Apocrine Ductal Carcinoma In Situ Presenting as a Large, Cystic Breast Mass: An Uncommon Presentation of a Rare Breast Lesion.
    Seo KJ; Whang IY
    Breast J; 2017 Sep; 23(5):594-595. PubMed ID: 28252232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic pitfalls in mammary pathology. Case 2. Atypical duct hyperplasia within columnar cell changes with atypia].
    Vincent-Salomon A
    Ann Pathol; 2009 Jun; 29(3):194-8. PubMed ID: 19619825
    [No Abstract]   [Full Text] [Related]  

  • 9. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Minimally Invasive Apocrine Carcinoma Derived from Ductal Adenoma].
    Moro K; Koyama Y; Nagahashi M; Hasegawa M; Toshikawa C; Tsuchida J; Hanyu T; Ishikawa T; Shimada Y; Sakata J; Kameyama H; Kobayashi T; Minagawa M; Kosugi S; Kato T; Watanabe G; Ajioka Y; Wakai T
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):235-7. PubMed ID: 27067689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apocrine intraductal carcinoma in situ in nevus sebaceus: two case reports.
    Llamas-Velasco M; Requena L; Podda M; Weidenthaler-Barth B; Rütten A
    J Cutan Pathol; 2014 Dec; 41(12):944-9. PubMed ID: 25302933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases.
    Moriya T; Sakamoto K; Sasano H; Kawanaka M; Sonoo H; Manabe T; Ito J
    Mod Pathol; 2000 Jan; 13(1):13-8. PubMed ID: 10658905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upgrade Rate and Imaging Features of Atypical Apocrine Lesions.
    Chang Sen LQ; Berg WA; Carter GJ
    Breast J; 2017 Sep; 23(5):569-578. PubMed ID: 28333404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
    D'Arcy C; Quinn C
    J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apocrine mammary carcinoma. A clinicopathologic study of 72 cases.
    Abati AD; Kimmel M; Rosen PP
    Am J Clin Pathol; 1990 Oct; 94(4):371-7. PubMed ID: 2171320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An immunohistochemical analysis of extramammary Paget's disease compared with mammary Paget's disease].
    Hasebe T; Yamamichi N; Konishi F; Mukawa A
    Gan No Rinsho; 1988 Feb; 34(2):159-66. PubMed ID: 2831411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human breast carcinomal tissues display distinctive FTIR spectra: implication for the histological characterization of carcinomas.
    Gao T; Feng J; Ci Y
    Anal Cell Pathol; 1999; 18(2):87-93. PubMed ID: 10468405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.